Top Stocks
Fetching live market data...
Fingo
Corporates

Eris Lifesciences promoters declare 53.92% stake with no undisclosed encumbrance

2 min read
Sreenidhi Das
27 May 2026 at 2:51 pm
2 min read

Eris Lifesciences Limited submitted a disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, reporting the promoter and promoter group shareholding as of March 31, 2026. Kaushal Kamlesh Shah, Promoter, signed and filed the declaration on behalf of all promoters and the promoter group of Eris Lifesciences Limited. The declaration was signed on April 6, 2026, and was submitted to BSE and the National Stock Exchange of India Limited on May 27, 2026, covering the financial year ended March 31, 2026.

Promoters and the promoter group collectively held 7,47,08,744 equity shares of Eris Lifesciences Limited, representing approximately 53.92% of the total paid-up equity share capital at the end of financial year 2025-26. The shareholding count and percentage were computed based on the paid-up equity share capital of Eris Lifesciences Limited as on the reporting date of March 31, 2026.

The filing confirmed that no encumbrance has been created on these promoter-held shares, directly or indirectly, beyond those already disclosed during the financial year. The declaration covers all shares held by the promoter and promoter group of Eris Lifesciences Limited and confirms the encumbrance status of these holdings as on March 31, 2026.

The disclosure was submitted to BSE Limited and the National Stock Exchange of India Limited. Equity shares of Eris Lifesciences Limited are listed on BSE under scrip code 540596 and on NSE under the symbol ERIS. Kaushal Kamlesh Shah, a promoter based in Ahmedabad, submitted the declaration for and on behalf of all promoters and the promoter group of Eris Lifesciences Limited.

Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.

Public Tags